Insider Selling: Zoetis Inc. (NYSE:ZTS) EVP Sells 652 Shares of Stock

Zoetis Inc. (NYSE:ZTS - Get Free Report) EVP Roxanne Lagano sold 652 shares of the company's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total transaction of $110,840.00. Following the sale, the executive vice president now owns 15,129 shares of the company's stock, valued at approximately $2,571,930. The trade was a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Roxanne Lagano also recently made the following trade(s):

• On Monday, March 10th, Roxanne Lagano sold 326 shares of Zoetis stock. The stock was sold at an average price of $170.00, for a total value of $55,420.00.

Zoetis Stock Up 0.8%

Shares of NYSE ZTS traded up $1.34 during trading on Friday, reaching $169.95. The company had a trading volume of 649,969 shares, compared to its average volume of 2,534,471. Zoetis Inc. has a 12-month low of $139.70 and a 12-month high of $200.33. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09. The business's 50-day moving average is $157.24 and its 200 day moving average is $164.41. The stock has a market cap of $75.66 billion, a PE ratio of 31.09, a P/E/G ratio of 2.78 and a beta of 0.94.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.20 billion. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. Zoetis's revenue for the quarter was up 1.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.38 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.18%. The ex-dividend date is Friday, July 18th. Zoetis's dividend payout ratio is currently 35.91%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the stock. UBS Group cut their price target on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a report on Wednesday, May 7th. Barclays boosted their price target on shares of Zoetis from $242.00 to $244.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Stifel Nicolaus lowered their price objective on shares of Zoetis from $180.00 to $165.00 and set a "buy" rating for the company in a report on Monday, April 14th. Piper Sandler lifted their price objective on Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a research report on Monday, May 12th. Finally, Morgan Stanley decreased their target price on Zoetis from $243.00 to $238.00 and set an "overweight" rating for the company in a research report on Friday, February 14th. One research analyst has rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $212.75.

Institutional Investors Weigh In On Zoetis

Institutional investors have recently modified their holdings of the business. Nova Wealth Management Inc. purchased a new stake in shares of Zoetis during the 1st quarter valued at about $25,000. 1248 Management LLC bought a new position in Zoetis during the first quarter valued at approximately $27,000. Atlantic Edge Private Wealth Management LLC boosted its holdings in Zoetis by 482.8% in the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company's stock worth $28,000 after purchasing an additional 140 shares during the last quarter. Rakuten Securities Inc. grew its position in Zoetis by 5,533.3% in the 4th quarter. Rakuten Securities Inc. now owns 169 shares of the company's stock worth $28,000 after purchasing an additional 166 shares during the period. Finally, Saudi Central Bank purchased a new stake in Zoetis during the 1st quarter valued at $29,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.